- Report
- August 2026
- 283 Pages
Global
From €5260EUR$5,850USD£4,509GBP
- Report
- August 2026
- 285 Pages
Global
From €5260EUR$5,850USD£4,509GBP
- Report
- August 2026
- 368 Pages
Global
From €5260EUR$5,850USD£4,509GBP
- Report
- August 2026
- 364 Pages
Global
From €5260EUR$5,850USD£4,509GBP
- Report
- August 2026
- 276 Pages
Global
From €5260EUR$5,850USD£4,509GBP
- Report
- August 2026
- 529 Pages
Global
From €5260EUR$5,850USD£4,509GBP
- Report
- August 2026
- 425 Pages
Global
From €5260EUR$5,850USD£4,509GBP
- Report
- June 2026
- 110 Pages
Global
From €4271EUR$4,750USD£3,661GBP
- Report
- June 2026
- 188 Pages
Global
From €4271EUR$4,750USD£3,661GBP
- Report
- January 2026
- 140 Pages
Global
From €4271EUR$4,750USD£3,661GBP
- Report
- April 2026
- 180 Pages
Global
From €4271EUR$4,750USD£3,661GBP
- Report
- April 2026
- 120 Pages
Global
From €4271EUR$4,750USD£3,661GBP
- Report
- April 2026
- 136 Pages
Global
From €2696EUR$2,999USD£2,312GBP
€3596EUR$3,999USD£3,082GBP
- Report
- April 2026
- 146 Pages
Global
From €2696EUR$2,999USD£2,312GBP
€3596EUR$3,999USD£3,082GBP
- Report
- April 2026
- 149 Pages
Global
From €2696EUR$2,999USD£2,312GBP
€3596EUR$3,999USD£3,082GBP
- Report
- April 2026
- 140 Pages
Global
From €2696EUR$2,999USD£2,312GBP
€3596EUR$3,999USD£3,082GBP
- Report
- April 2026
- 147 Pages
Global
From €2696EUR$2,999USD£2,312GBP
€3596EUR$3,999USD£3,082GBP
- Report
- August 2025
- 223 Pages
Global
From €2248EUR$2,500USD£1,927GBP
- Report
- April 2026
- 180 Pages
Global
From €4271EUR$4,750USD£3,661GBP
- Report
- July 2026
- 181 Pages
Global
From €4271EUR$4,750USD£3,661GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more